PTGS1 and diabetes mellitus: Therefore, it is logical to hypothesise that Cmpd17b treatment may be increasing the production of vasodilator prostanoids, likely via Ptgs1 to enhance endothelium-dependent relaxation in diabetes, which results in the compensatory downregulation of Ptgis gene expression.